Company: SGBAF
Filing Date: 2025-01-17
Form Type: DRS/A
Source: 0000950123-25-000378
Chunk: 288

Company: SES S.A.
Filing Date: 2025-01-17
Form: DRS/A
Chunk 288
---
   (503 | ) |     |         |  (57 | ) |     |                     |  (30 | ) |     |       |   (603 | ) |
| Impairment expense                                        |     |           |    — |   |     |         |    (56 | ) |     |         |    — |   |     |                     |    — |   |     |       |    (56 | ) |
| Impairment reversal                                       |     |           |    — |   |     |         |     30 |   |     |         |    — |   |     |                     |    — |   |     |       |     30 |   |
| Disposals1                                                |     |           |    8 |   |     |         |    151 |   |     |         |    3 |   |     |                     |    6 |   |     |       |    168 |   |
| Retirements2                                              |     |           |    9 |   |     |         |    805 |   |     |         |  154 |   |     |                     |   25 |   |     |       |    993 |   |
| Impact of currency translation                            |     |           |    2 |   |     |         |    155 |   |     |         |   11 |   |     |                     |    5 |   |     |       |    173 |   |
| Balance as of December 31, 2023                           |     |           | (209 | ) |     |         | (7,536 | ) |     |         | (564 | ) |     |                     | (238 | ) |     |       | (8,547 | ) |
| Net book value as of December 31, 2023                    |     |           |   72 |   |     |         |  2,705 |   |     |         |  203 |   |     |                     |   62 |   |     |       |  3,042 |   |

F-47

Confidential Treatment Requested by SES Pursuant to 17 C.F.R. Section 200.83 Consolidated financial statements as of and for the years ended December 31, 2023 and December 31, 2022

| 1 | Sale of AMC-11 |

| 2 |